Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02725177 · ClinicalTrials.gov registry record · NA
Ocular Sarcoidosis Open Label Trial of ACTHAR Gel
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02725177: Completed NA study, sponsored by The Cleveland Clinic.
NCT02725177 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02725177, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Treatment with ACTHAR Gel will result in a reduction of ocular inflammation in patients with active ocular sarcoidosis that requires systemic immunosuppressant therapy (hypothesis)
Primary Outcome
The primary outcome was percentage of patients meeting at least one of the following variables 1) improved visual acuity, 2) resolution of intraocular inflammation, 3) ability to taper ocular or oral steroids by at least 50% or 4) reduction of cystoid macular edema, with no worsening of any single one and no need for additional sarcoidosis therapies at 24 weeks .
Interventions
- DRUG Repository Corticotropin Injection
- DRUG Repository Corticotropin Injection -Treatment Extension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2016-07 |
| Est. Completion | 2022-03 |
| Phase | NA |
What the finished NCT02725177 record still lists
NCT02725177 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Repository Corticotropin Injection is the first listed.
NCT02725177 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02725177 about?
NCT02725177 is a clinical study titled "Ocular Sarcoidosis Open Label Trial of ACTHAR Gel". Treatment with ACTHAR Gel will result in a reduction of ocular inflammation in patients with active ocular sarcoidosis that requires systemic immunosuppressant therapy (hypothesis)
What is the current status of trial NCT02725177?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2016-07. Estimated completion is 2022-03.
What interventions are being tested in trial NCT02725177?
The interventions under investigation include: Repository Corticotropin Injection (DRUG), Repository Corticotropin Injection -Treatment Extension (DRUG).
Who is sponsoring clinical trial NCT02725177?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02725177's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia